Characteristic | Male | Female | ||||
---|---|---|---|---|---|---|
Normal Weight | Overweight | Obese | Normal Weight | Overweight | Obese | |
Participants, No. | 1432 | 1876 | 396 | 2432 | 632 | 84 |
Age, median (IQR), y | 40 (32–53) | 48 (38–56) | 46 (39–55) | 39 (33–45) | 47 (39–53) | 48 (44–53) |
BMI, median (IQR), Kg/m2 | 22.4 (21.0–23.2) | 25.7 (24.8–26.7) | 29.1 (28.4–30.0) | 20.9 (19.7–22.2) | 25.4 (24.6–26.4) | 29.7 (28.6–31.6) |
Waist circumference, median (IQR), cm | 78 (76–81) | 82 (78–86) | 88 (80–94) | 71 (66–80) | 80 (77–82) | 84 (80–87) |
Systolic BP, median (IQR), mm Hg | 120 (114–130) | 126 (118–138) | 130 (120–142) | 108 (100–118) | 120 (114–134) | 124 (112–138) |
Diastolic BP, median (IQR), mm Hg | 74 (66–82) | 80 (74–88) | 82 (76–90) | 68 (60–74) | 76 (68–82) | 84 (74–88) |
Antihypertensive, % | 3.4 | 9.6 | 18.2 | 1.1 | 6.3 | 23.8 |
Antidiabetes, % | 3.1 | 3.0 | 1.0 | 0.5 | 1.3 | 0 |
Lipid-lowering | 3.8 | 8.1 | 10.2 | 1.3 | 5.2 | 5.8 |
TC, median (IQR), mmol/L | 4.5 (4.0–5.1) | 4.7 (4.2–5.3) | 5.0 (4.3–5.4) | 4.4 (3.9–4.8) | 4.6 (4.1–5.3) | 4.9 (4.3–5.2) |
LDL-c, median (IQR), mmol/L | 2.5 (2.0–3.0) | 2.6 (2.1–3.1) | 2.6 (2.0–3.0) | 2.3 (1.9–2.7) | 2.7 (2.1–3.2) | 2.5 (2.1–3.0) |
HDL-c, median (IQR), mmol/L | 1.3 (1.2–1.5) | 1.2 (1.0–1.4) | 1.1 (1.0–1.3) | 1.6 (1.4–1.8) | 1.4 (1.2–1.6) | 1.4 (1.2–1.7) |
Triglycerides, median (IQR), mmol/L | 1.2 (0.9–1.8) | 1.7 (1.2–2.4) | 2.3 (1.6–2.9) | 0.9 (0.7–1.1) | 1.3 (0.9–1.7) | 1.6 (1.2–1.8) |
Glucose, median (IQR), mmol/L | 4.7 (4.4–5.1) | 4.9 (4.6–5.3) | 5.1 (4.7–5.6) | 4.7 (4.4–5.0) | 4.9 (4.5–5.3) | 5.1 (4.8–5.4) |
eGFR, median (IQR), mL/min/1.73 m2 | 79 (72–91) | 77 (70–87) | 78 (71–86) | 119 (102–139) | 114 (98–133) | 121 (93–129) |
Current smokers, % | 36.9 | 36.9 | 33.3 | 0.3 | 0 | 0 |
Physical inactivity, % | 46.9 | 48.5 | 50.1 | 38.1 | 55.1 | 61.3 |